Horizon Kinetics Medical ETF Rating → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free MEDX Stock Alerts $29.18 -0.04 (-0.14%) (As of 06/7/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHoldingsRatingsTrendsStock AnalysisChartDividendHoldingsRatingsTrends Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy2.61Holdings in MEDX have an aggregate rating of Moderate Buy based on 351 analyst ratings issued in the past year covering 32 companies (87.8% of the portfolio).MEDX Aggregate Price Target$37.6629.02% UpsideHigh Prediction$49.85Average Prediction$37.66Low Prediction$26.37Holdings in MEDX have an aggregate price target of $37.66 and a range of $26.37 to $49.85 covering 32 companies (87.8% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 32 MEDX Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.11%LLYEli Lilly and Company$849.99+1.5%4 of 5 stars2.84$787.53 -7.3%19Analyst ForecastInsider Selling7.08%ABBVAbbVie$169.42+0.5%5 of 5 stars2.86$178.21 5.2%14Analyst Upgrade5.99%AMGNAmgen$305.02-0.2%5 of 5 stars2.52$305.65 0.2%21Analyst RevisionPositive News5.68%AZNAstraZeneca$80.02-1.0%2 of 5 stars2.67$88.00 10.0%95.03%MRKMerck & Co., Inc.$130.67+0.1%4 of 5 stars2.69$133.00 1.8%13Analyst Forecast4.38%JNJJohnson & Johnson$147.08+0.5%5 of 5 stars2.38$174.07 18.4%13Analyst Forecast4.35%PFEPfizer$28.58-0.8%5 of 5 stars2.40$35.86 25.5%154.27%BMYBristol-Myers Squibb$41.48+1.5%5 of 5 stars2.11$60.00 44.6%194.16%REGNRegeneron Pharmaceuticals$1,002.95+0.2%4 of 5 stars2.76$989.86 -1.3%21Analyst ForecastInsider SellingNews Coverage4.05%BIIBBiogen$225.43-2.8%5 of 5 stars2.65$286.50 27.1%26Analyst ForecastAnalyst RevisionNews Coverage3.44%CRSPCRISPR Therapeutics$57.87-3.5%2 of 5 stars2.31$73.46 26.9%163.25%ALKSAlkermes$23.91-1.0%5 of 5 stars2.50$36.78 53.8%10Analyst ForecastPositive News2.96%GSKGSK$41.21-0.8%3 of 5 stars2.33$47.00 14.0%62.79%IONSIonis Pharmaceuticals$38.95-2.3%4 of 5 stars2.71$59.54 52.9%14Positive News2.57%ALNYAlnylam Pharmaceuticals$152.78+2.3%5 of 5 stars2.59$216.19 41.5%17Positive News1.96%BCYCBicycle Therapeutics$23.04-0.3%1 of 5 stars2.86$46.86 103.4%71.94%NTLAIntellia Therapeutics$22.73-1.0%3 of 5 stars2.69$66.77 193.7%13Analyst ForecastNews Coverage1.38%BEAMBeam Therapeutics$23.21-3.6%1 of 5 stars2.38$40.18 73.1%13Positive NewsGap Down1.06%LTRNLantern Pharma$5.58-4.0%0 of 5 stars2.0011.00%EDITEditas Medicine$5.30-2.4%4 of 5 stars2.45$13.27 150.4%110.90%GALTGalectin Therapeutics$2.60-1.9%1 of 5 stars3.00$11.00 323.1%1News CoverageGap Down0.70%HLNHaleon$8.52-0.7%3 of 5 stars2.805Analyst ForecastNews Coverage0.45%GEHCGE HealthCare Technologies$76.34-0.9%5 of 5 stars2.55$94.09 23.3%11Positive News0.44%REPLReplimune Group$7.90+11.1%4 of 5 stars3.00$16.67 111.0%3Analyst ForecastNews CoverageGap UpHigh Trading Volume0.44%TSVT2seventy bio$3.92-5.1%3 of 5 stars2.50$12.43 217.5%10Analyst DowngradeNews Coverage0.40%SDZNYSandoz Group$35.76+0.5%0 of 5 stars3.0030.28%ALLOAllogene Therapeutics$2.32-3.7%3 of 5 stars2.70$9.95 328.9%10Analyst Revision0.22%VTRSViatris$10.47+0.5%0 of 5 stars1.33$11.00 5.1%30.20%BLUEbluebird bio$0.91-1.1%2 of 5 stars2.20$5.46 503.6%100.13%PACBPacific Biosciences of California$2.01-2.0%2 of 5 stars2.53$6.38 217.2%15Gap Down0.09%SLRXSalarius Pharmaceuticals$0.41-4.6%0 of 5 stars2.001Gap UpHigh Trading Volume0.05%MURAMural Oncology$3.35+0.3%2 of 5 stars3.00$13.00 288.1%1Positive News This page (NASDAQ:MEDX) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
